Cargando…

Clinical, Dermoscopic, and Histological Characteristics of Melanoma Patients According to the Age Groups: A Retrospective Observational Study

Background: Although the role of melanoma risk factors is well documented, their correlation with patients’ age is less frequently analyzed. Method: The analysis was performed among 189 melanoma patients in different age groups, including <30 years, 31–60 years, and >60 years, to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Słowińska, Monika, Czarnecka, Iwona, Czarnecki, Robert, Tatara, Paulina, Nasierowska-Guttmejer, Anna, Lorent, Małgorzata, Cierniak, Szczepan, Owczarek, Witold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305549/
https://www.ncbi.nlm.nih.gov/pubmed/37374151
http://dx.doi.org/10.3390/life13061369
Descripción
Sumario:Background: Although the role of melanoma risk factors is well documented, their correlation with patients’ age is less frequently analyzed. Method: The analysis was performed among 189 melanoma patients in different age groups, including <30 years, 31–60 years, and >60 years, to investigate the risk factors, topography, and coexistence of morphological features of 209 melanomas (dermoscopic and histopathological). Results: Among the youngest age group, no correlation with the presence of estimated risk factors was found. The most common dermoscopic pattern was spitzoid and multicomponent asymmetric. The group of middle-aged patients was the most diverse in terms of the occurrence of risk factors, solar lentiginosis, dermoscopic patterns, topography, histological subtypes, and invasiveness of melanomas. The oldest group characterized a strong correlation between solar lentiginosis, NMSC comorbidity, the prevalence of facial melanomas, the dermoscopic pattern of melanoma arising on chronic sun-damaged skin, and regression. Conclusion: The findings regarding the presence of age-specific features in melanoma patients, especially in the youngest and middle-aged groups, might be helpful for clinicians and to target secondary prevention efforts.